Clinical trial
Effects of AFQ056 and Baclofen on Meal-Induced Gastroesophageal Reflux
NCT00414856 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00414856 |
|---|---|
| Title | Effects of AFQ056 and Baclofen on Meal-Induced Gastroesophageal Reflux |
| Official title | A Multi-Center, Randomized, Double-Blind, Placebo- and Positive-Control, Double-Dummy, 3 Parallel Cohort, Two-Way Crossover Single Oral Dose Study in GERD (Gastro Esophageal Reflux Disease) Patients to Evaluate the Effects of AFQ056 and Baclofen (Positive Control) on the Incidence of Meal-Induced… |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Gastroesophageal Reflux Disease |
| Intervention type | Drug |
| Interventions | AFQ056 |
| Enrollment | 34 |
| Start date | Aug 1, 2006 |
| First posted | Dec 22, 2006 |
| Last update posted | Jun 22, 2007 |
| Countries | Belgium, France, Germany, Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: